We can't find the internet
Attempting to reconnect
34818.1 IP-LS
34818.1 IP-LS
Résumé
ScaiBmd Toxicity
Textes supplémentaires
Abstract
We aim to establish immune signature(s) predictive of early toxicity in view of oncological status following multimodal therapy of patients with head and neck squamous cell carcinoma. A partnership between the Inselspital Bern and data science company Scailyte AG forms the basis for this project.
Participants
Vijay Tiwari
Wirtschaftspartner
tiwari@scailyte.com
Scailyte AG Vijay Tiwari Industriestrasse 12 6210 Sursee LU CH
Michaela Medová
Kontaktperson
michaela.medova@dbmr.unibe.ch
Universität Bern DBMR Michaela Medová Murtenstrasse 35 3008 Bern BE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2019-05-31
- Date de fin
- 2023-02-28
- Coûts totaux approuvés
- CHF 388887.64
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- B720 General practice, medical training 100.0%